Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are Corporate Insiders At These Companies Going Against The Bearish Crowd?

Page 1 of 2

There is hardly any doubt that we have been in a bear market for quite some time and many investment gurus feel the same way, and feel that it is hard to see the light at the end of the tunnel at the moment. The Dow Jones Industrial Average closed 312.78 points in the red on Monday, which points to the fact that everything that happens in the U.S equity markets is not just a simple correction. Even so, many corporate executives have started to pile up more shares of their companies, which could suggest confidence in the prospects of their firms. The Insider Monkey team identified three companies that have seen unusual levels of insider buying activity lately, so it might be worthwhile to examine what might have propelled insiders to turn against the market. Ashford Inc. (NYSEMKT:AINC), Middleburg Financial Corp. (NASDAQ:MBRG), and Helmerich & Payne Inc. (NYSE:HP) are the three companies in question that recently had a large volume of insider buying.

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 118% over the ensuing 36 months, outperforming the S&P 500 Index by nearly 61 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Going back to the three theoretically promising companies, Ashford Inc. (NYSEMKT:AINC) saw its Chief Strategy Officer buy stock last week. J. Robinson Hays III acquired 1,823 shares at prices in the range of $62.99 to $64, enlarging his holding to exactly 10,000 shares. It is also worth noting that this is the first insider purchase at this company so far this year, which may emphasize its significance. The provider of asset management and other related services to companies working in the hospitality industry recently announced a business combination with Remington Holdings, a hotel property and project management company. As a result, Ashford intends to set up a new subsidiary structure that will purchase an economic stake of 80% in Remington and the entire business of Ashford. Meanwhile, the shares of the company have lost more than 33% since the beginning of the year, so the recent insider transactions might be somewhat related to Ashford’s recently-announced combination as well as shares’ depressed value. HG Vora Capital Management, founded by Parag Vora, represents the largest equity holder of Ashford Inc. (NYSEMKT:AINC) in our database, with an ownership stake of 198,000 shares.

Follow Ashford Inc (NYSEMKT:AINC)
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!